in this issue
Regions :: Western Europe :: France
Rhodia Acquisition Underpins Solvay's Earnings and Sales
7:31 AM MST | February 16, 2012 | Sotirios Frantzanas
Solvay says net profits and net sales, on a proforma basis, increased 5% and 3% in the fourth quarter of 2011, to approximately €3 billion ($3.9 billion) and €122 million, respectively. Recurring Ebitda (Rebitda) and recurring Ebit (Rebit) on a proforma basis decreased 23% and 39% year over year, to €355 million and €184 million, respectively, Solvay says. The proforma basis presents Solvay's results as if last year's acquisition of Rhodia had become effective from January 1, 2010, the company says. It also harmonizes the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee